Obesity Nutritional, Metabolic, Endocrine Obesity
Conditions
Interventions
Bariatric surgery (surgical procedures developed for the primary purpose of weight loss currently laparoscopic gastric banding, sleeve gastrectomy and roux-en-y gastric bypass)
2000 patients undergoi
Sponsors
NHS Greater Glasgow and Clyde (UK)
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Undergoing bariatric surgery in NHS secondary care and private practice in Scotland, UK
Exclusion criteria
Exclusion criteria: Does not meet inclusion criteria
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 10-year mortality | — |
Secondary
| Measure | Time frame |
|---|---|
| In the 10 years following bariatric surgery: 1. Change in weight / body mass index (BMI) from pre-bariatric surgery weight 2. Rate of incident type 2 diabetes 3. Incidence of fatal and non-fatal coronary heart disease, cardiovascular disease, cancer and fractures 4. Incidence of incidence of nutritional deficiencies 5. Change in incidence of depression and anxiety compared to baseline level pre-operatively 6. Incidence of complications immediately post-operatively and the need for readmission for revisional procedures 7. Change in health-related quality of life compared to baseline level pre-operatively 8. Change in glycaemic control, cardiovascular risk factors, chronic kidney disease (CKD), retinopathy and medications prescribed in patients with diabetes compared to equally obese patient with diabetes who did not have bariatric surgery 9. Cost of the procedure and follow-up (to inform cost-effectiveness analysis) | — |
Countries
Scotland, United Kingdom
Outcome results
None listed